Xiaodong Su

机构：Sun Yat-sen University, Peking University, Lanzhou University of Technology, Sun Yat-sen University Cancer Center, First Hospital of Lanzhou University, Lanzhou University · ORCID：0000-0002-5956-2126

发表论文 82 篇 · 总被引 2143 次 · h-index 20

代表论文

• Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial (2024 · The Lancet Respiratory Medicine · 被引 33)
• Stalled oligodendrocyte differentiation in IDH-mutant gliomas (2023 · Genome Medicine · 被引 29)
• Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial (2023 · Journal of Translational Medicine · 被引 23)
• Advances in the use of dexmedetomidine during the perioperative period to improve postoperative sleep quality in patients undergoing surgery (2024 · Journal of International Medical Research · 被引 9)
• Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy (2025 · Tomography · 被引 3)
• CCL5 hi Macrophages Interact with CD8 + T Cells and Potentiate Responsiveness to PD‐1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma (2025 · Advanced Science · 被引 3)